Adaption of seasonal H1N1 influenza virus in mice

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Xu, Lili ^a,b,c   Bao, Linlin ^a,b,c   Li, Fengdi ^a,b,c   Lv, Qi ^a,b,c   Ma, Yila ^a,b,c   Zhou, Jiangfang ^d   Xu, Yanfeng ^a,b,c   Deng, Wei ^a,b,c   Zhan, Lingjun ^a,b,c   Zhu, Hua ^a,b,c   Ma, Chunmei ^a,b,c   Shu, Yuelong ^d   Qin, Chuan ^a,b,c  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b BEIJING HOSPITAL   (China)

^c State Administration of Traditional Chinese Medicine   (China)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

ADAPTIVE BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL DIVISION; CELL STRAIN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; IMMUNE RESPONSE; INFLUENZA VIRUS A H1N1; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PNEUMONIA; RECEPTOR BINDING; SEASONAL INFLUENZA; VIRUS VIRULENCE; ADAPTATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; CHEMISTRY; DNA SEQUENCE; DOG; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; KINETICS; LUNG; MOLECULAR GENETICS; MUTATION; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; SEASON; SEQUENCE ALIGNMENT; VIROLOGY; VIRUS CULTURE; VIRUS GENOME; VIRUS REPLICATION;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOKINES; DOGS; GENOME, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; KINETICS; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; PROTEIN BINDING; SEASONS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 83455181813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028901     Document Type: Article

References (54)

1. Treanor JD, (2007) Influenza-the goal of control. N Engl J Med 357: 1439-1441.
2. Cate TR, (1987) Clinical manifestations and consequences of influenza. Am J Med 82: 15-19.
3. Whitley RJ, Monto AS, (2006) Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 194 (Suppl 2): S133-138.
4. Sweet C, Smith H, (1980) Pathogenicity of influenza virus. Microbiol Rev 44: 303-330.
5. Ward AC, (1997) Virulence of influenza A virus for mouse lung. Virus Genes 14: 187-194.
6. Hirst GK, (1947) Studies on the Mechanism of Adaptation of Influenza Virus to Mice. J Exp Med 86: 357-366.
7. Raut S, Hurd J, Blandford G, Heath RB, Cureton RJ, (1975) The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus. J Med Microbiol 8: 127-136.
8. Xu L, Bao L, Lv Q, Deng W, Ma Y, et al. (2010) A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 7: 325.
9. Brown EG, (1990) Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol 64: 4523-4533.
10. Gitelman AK, Kaverin NV, Kharitonenkov IG, Rudneva IA, Zhdanov VM, (1984) Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice. Virology 134: 230-232.
11. Hartley CA, Reading PC, Ward AC, Anders EM, (1997) Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol 142: 75-88.
12. Kaverin NV, Finskaya NN, Rudneva IA, Gitelman AK, Kharitonenkov IG, et al. (1989) Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content. Arch Virol 105: 29-37.
13. Smeenk CA, Brown EG, (1994) The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68: 530-534.
14. Brown EG, Bailly JE, (1999) Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res 61: 63-76.
15. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M, (2001) Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci U S A 98: 6883-6888.
16. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA, (2008) A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105: 4381-4386.
17. Jiao P, Tian G, Li Y, Deng G, Jiang Y, et al. (2008) A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82: 1146-1154.
18. Li Z, Chen H, Jiao P, Deng G, Tian G, et al. (2005) Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 79: 12058-12064.
19. Narasaraju T, Sim MK, Ng HH, Phoon MC, Shanker N, et al. (2009) Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect 11: 2-11.
20. Rudneva IA, Kaverin NV, Varich NL, Gitelman AK, Makhov AM, et al. (1986) Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain. Arch Virol 90: 237-248.
21. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y, (2007) Adaptation of an H7N7 equine influenza A virus in mice. J Gen Virol 88: 547-553.
22. Song MS, Pascua PN, Lee JH, Baek YH, Lee OJ, et al. (2009) The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol 83: 12325-12335.
23. Lin T, Wang G, Li A, Zhang Q, Wu C, et al. (2009) The hemagglutinin structure of an avian H1N1 influenza A virus. Virology 392: 73-81.
24. Zamarin D, Ortigoza MB, Palese P, (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80: 7976-7983.
25. Auewarakul P, Suptawiwat O, Kongchanagul A, Sangma C, Suzuki Y, et al. (2007) An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 81: 9950-9955.
26. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, et al. (1985) Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40: 431-439.
27. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, et al. (1964) Antiviral Activity of 1-Adamantanamine (Amantadine). Science 144: 862-863.
28. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
29. Xu Q, Wang W, Cheng X, Zengel J, Jin H, (2010) Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol 84: 4936-4945.
30. Glaser L, Stevens J, Zamarin D, Wilson IA, Garcia-Sastre A, et al. (2005) A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79: 11533-11536.
31. Smeenk CA, Wright KE, Burns BF, Thaker AJ, Brown EG, (1996) Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res 44: 79-95.
32. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358: 261-273.
33. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, et al. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360: 2616-2625.
34. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
35. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al. (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72: 7367-7373.
36. Ning ZY, Luo MY, Qi WB, Yu B, Jiao PR, et al. (2009) Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Vet Res Commun 33: 895-903.
37. Gambaryan AS, Boravleva EY, Matrosovich TY, Matrosovich MN, Klenk HD, et al. (2005) Polymer-bound 6′ sialyl-N-acetyllactosamine protects mice infected by influenza virus. Antiviral Res 68: 116-123.
38. Schulman JL, Palese P, (1977) Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol 24: 170-176.
39. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM, (2000) Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 74: 6105-6116.
40. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM, (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4: e1000115.
41. To KF, Chan PK, Chan KF, Lee WK, Lam WY, et al. (2001) Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63: 242-246.
42. Chan PK, (2002) Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34 (Suppl 2): S58-64.
43. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101: 643-649.
44. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
45. Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, et al. (2008) Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 225: 68-84.
46. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V, (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376: 53-59.
47. Skoner DP, Gentile DA, Patel A, Doyle WJ, (1999) Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 180: 10-14.
48. Sun J, Madan R, Karp CL, Braciale TJ, (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15: 277-284.
49. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
50. Nakajima N, Hata S, Sato Y, Tobiume M, Katano H, et al. (2010) The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis 63: 67-71.
51. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
52. Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC, (2007) Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 75: 3102-3111.
53. Mahalingam S, Farber JM, Karupiah G, (1999) The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo. J Virol 73: 1479-1491.
54. Liu MT, Armstrong D, Hamilton TA, Lane TE, (2001) Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 166: 1790-1795.